生物技术公司Opus Genetics Inc宣布，其发行的票据中最多10%的部分，可由投资机构奥伯兰资本（Oberland Capital）自主选择转换为公司普通股，转换价格设定为每股6.72美元。此项条款为奥伯兰资本提供了将债权转换为股权的灵活性，潜在增加了其对公司的持股比例。转换价格的设定也反映了市场对公司股权价值的当前评估。
生物技术公司Opus Genetics Inc宣布，其发行的票据中最多10%的部分，可由投资机构奥伯兰资本（Oberland Capital）自主选择转换为公司普通股，转换价格设定为每股6.72美元。此项条款为奥伯兰资本提供了将债权转换为股权的灵活性，潜在增加了其对公司的持股比例。转换价格的设定也反映了市场对公司股权价值的当前评估。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.